Robin Shattock is a professor of Mucosal Infection and Immunity at Imperial College, London. The main focus of his research is the investigation of the mechanisms of mucosal HIV transmission and development of novel preventative strategies.
Prof Shattock has secured funding from the Wellcome Trust, NIH, European Commission, and the Bill and Melinda Gates Foundation. He currently holds a Grand Challenges for Global Health Initiative program grant to optimize vaginal vaccination against HIV infection. He also leads the Mucosal Discovery Team for CHAVI. In addition, he coordinates the EUROPRISE Network of Excellence on Vaccines and Microbicides that coordinates EU funded research across 40 institutions. He provides scientific coordination for European Microbicide program CHAARM (Combined Highly Active Anti-Retroviral Microbicides).
Prof. Shattock Chairs the Research and Advisory Steering Committee of the International Partnership for Microbicides and is a member of the Scientific Advisory boards of Global HIV Vaccine Enterprise Scientific Committee (GHVE).